Catalyst Wire Dossier Catalyst Wire Dossier

DaxibotulinumtoxinA for Injection (DAXI for Injection)

daxibotulinumtoxinA · Revance Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DaxibotulinumtoxinA for Injection (DAXI for Injection), covering 2023-06-27 to 2023-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines [Phase 2]

See pricing